Hepatic Artery Infusional Floxuridine to Treat Pancreatic Cancer Liver Metastases

NCT03856658 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

14

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Adenocarcinoma
Liver Metastases

Interventions

DRUG: Floxuridine (FUDR)
DEVICE: Hepatic Artery Infusion Pump
DRUG: Heparinized Saline

Sponsor

Corewell Health West